EMD Millipore Corporation is accepting applications for the 2026 North American Advance Biotech Grant Program, an initiative designed to support emerging biopharmaceutical and biotechnology startups advancing toward commercialization. The program provides grant recipients with access to products, services, and expert consultation to help accelerate biomanufacturing and therapeutic development efforts.

This opportunity is intended for biotechnology companies located in or conducting substantial business in the United States or Canada. One selected winner will receive the Program Winner Prize, valued at $238,400. Two finalists will each receive $20k in credit, and semi-finalists won’t walk away empty-handed either. There’s NO IP sharing required to apply and 𝐧𝐨 𝐞𝐪𝐮𝐢𝐭𝐲 𝐫𝐞𝐪𝐮𝐢𝐫𝐞𝐝 from winners or finalists.

Applications are due by Thursday April 30th , 2026. To begin your application, click here.